Jaguar Health, Inc. (JAGX)
4.78
+0.25
(+5.52%)
USD |
NASDAQ |
Oct 09, 16:00
4.85
+0.07
(+1.46%)
After-Hours: 20:00
Jaguar Health Enterprise Value : 11.49M for Oct. 8, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 08, 2026 | 11.49M |
| October 07, 2026 | 11.64M |
| October 06, 2026 | 11.84M |
| October 05, 2026 | 11.55M |
| October 02, 2026 | 11.21M |
| October 01, 2026 | 11.30M |
| September 30, 2026 | 11.48M |
| September 29, 2026 | 11.74M |
| September 28, 2026 | 11.97M |
| September 25, 2026 | 12.51M |
| September 24, 2026 | 12.31M |
| September 23, 2026 | 12.91M |
| September 22, 2026 | 21.18M |
| September 21, 2026 | 10.88M |
| September 18, 2026 | 10.90M |
| September 17, 2026 | 10.91M |
| September 16, 2026 | 11.15M |
| September 15, 2026 | 11.11M |
| September 14, 2026 | 11.57M |
| September 11, 2026 | 11.55M |
| September 10, 2026 | 11.57M |
| September 09, 2026 | 11.80M |
| September 08, 2026 | 12.03M |
| September 04, 2026 | 12.92M |
| September 03, 2026 | 13.39M |
| Date | Value |
|---|---|
| September 02, 2026 | 13.57M |
| September 01, 2026 | 13.57M |
| August 31, 2026 | 13.86M |
| August 28, 2026 | 13.95M |
| August 27, 2026 | 14.22M |
| August 26, 2026 | 14.49M |
| August 25, 2026 | 14.51M |
| August 24, 2026 | 14.45M |
| August 21, 2026 | 14.23M |
| August 20, 2026 | 14.26M |
| August 19, 2026 | 14.51M |
| August 18, 2026 | 14.76M |
| August 17, 2026 | 14.29M |
| August 14, 2026 | 14.47M |
| August 13, 2026 | 13.82M |
| August 12, 2026 | 13.71M |
| August 11, 2026 | 13.82M |
| August 10, 2026 | 14.07M |
| August 07, 2026 | 14.63M |
| August 06, 2026 | 14.58M |
| August 05, 2026 | 15.14M |
| August 04, 2026 | 14.88M |
| August 03, 2026 | 14.88M |
| July 31, 2026 | 14.88M |
| July 30, 2026 | 15.07M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Omeros Corp. | 1.543B |
| ANI Pharmaceuticals, Inc. | 1.888B |
| Corcept Therapeutics, Inc. | 12.49B |
| Veru, Inc. | 18.15M |
| Johnson & Johnson | 645.94B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -12.80M |
| Revenue (Quarterly) | 1.225M |
| Total Expenses (Quarterly) | 13.91M |
| EPS Diluted (Quarterly) | -235.46 |
| Gross Profit Margin (Quarterly) | -22.04% |
| Profit Margin (Quarterly) | -1.05K% |
| Earnings Yield | -114.7K% |
| Normalized Earnings Yield | -98511.67 |